These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2437407)

  • 1. Diagnostic histochemical and immunohistochemical studies in malignant mesothelioma.
    Lucas JG; Tuttle SE
    J Surg Oncol; 1987 May; 35(1):30-4. PubMed ID: 2437407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
    Hammar SP; Bockus DE; Remington FL; Rohrbach KA
    Ultrastruct Pathol; 1996; 20(4):293-325. PubMed ID: 8837337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.
    Holden J; Churg A
    Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
    Sheibani K; Battifora H; Burke JS
    Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
    al-Saffar N; Hasleton PS
    Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis.
    Cappello F; Barnes L
    Pathology; 2001 May; 33(2):142-8. PubMed ID: 11358044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases.
    Wick MR; Loy T; Mills SE; Legier JF; Manivel JC
    Hum Pathol; 1990 Jul; 21(7):759-66. PubMed ID: 2193875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse malignant mesothelioma of pleura: diagnostic criteria based on an autopsy study.
    Adams VI; Unni KK
    Am J Clin Pathol; 1984 Jul; 82(1):15-23. PubMed ID: 6588749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
    Brown RW; Clark GM; Tandon AK; Allred DC
    Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression.
    Bateman AC; al-Talib RK; Newman T; Williams JH; Herbert A
    Histopathology; 1997 Jan; 30(1):49-56. PubMed ID: 9023557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
    Szpak CA; Johnston WW; Roggli V; Kolbeck J; Lottich SC; Vollmer R; Thor A; Schlom J
    Am J Pathol; 1986 Feb; 122(2):252-60. PubMed ID: 2418688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T
    Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects].
    Chenard-Neu MP; Bellocq JP; Maier A; Batzenschlager A
    Ann Pathol; 1990; 10(1):20-7. PubMed ID: 2328062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.
    Kawai T; Greenberg SD; Truong LD; Mattioli CA; Klima M; Titus JL
    Am J Pathol; 1988 Feb; 130(2):401-10. PubMed ID: 2449084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of tissue CEA-like substance as an aid in the differential diagnosis of malignant mesothelioma.
    Whitaker D; Sterrett GF; Shilkin KB
    Pathology; 1982 Jul; 14(3):255-8. PubMed ID: 6290965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistological study of malignant diffuse mesotheliomas of the pleura.
    Loosli H; Hurlimann J
    Histopathology; 1984 Sep; 8(5):793-803. PubMed ID: 6083969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.
    Cibas ES; Corson JM; Pinkus GS
    Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.